Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Axsome Therapeutics Stock a Buy Now?

TheMotleyFool

0 0

Is Axsome Therapeutics Stock a Buy Now?Photo, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Axsome Therapeutics (NASDAQ: AXSM) has had a transformative past 10 months. The biotech company started the year with no drugs on the market, and now its portfolio includes two therapies. That's partly why Axsome stock has crushed the market this year -- although it has been a bit of a roller-coaster ride.

Investors will want to know whether the drugmaker can maintain this momentum. If so, it might be a good idea to consider purchasing its shares today. With that said, let's see what the future may hold for Axsome Therapeutics.